[ad_1]
No private agreement from Germany for a greater offer of Vaccines for COVID-19. This was announced by the European Commission, explaining the reason why many more doses are reaching the country than the others.
The EU denies it, there was no private agreement from Germany on the vaccine
“To our knowledge, no Member State has received additional doses outside of the EU agreementA spokesman for the Commission said in the wake of the furious controversy over the additional doses of vaccines obtained by Germany.
The advance purchase agreement with BioNTech and Pfizer, the spokesperson specified, “has reserved 200 million doses of the vaccine for European citizens, offering the option to purchase up to 100 million additional doses”.
This option was activated yesterday, Monday, December 28, expanding the purchase to an additional 100 million doses.
Germany separates from the EU on vaccines? What really happened
“The starting point for the allocation of doses to Member States is the distribution key, based on the population”Explains the spokesperson. The inhabitants of a country, therefore, are only the point: then granted “possible adjustments between member states, according to their needs and demands”.
Some states, in fact, “may be interested in receiving more doses, while others may not beIn practice, Germany has opted for additional doses, but always within the European framework. Some countries may not be interested in buying additional doses of the Pfizer vaccine because it is more expensive or because others will sooner or later be authorized for emergency use.
How much does the EU pay for vaccines?
According to prices published this month on Twitter by Belgian Undersecretary Eva de Bleeker – never confirmed but not denied by the Commission – the Pfizer / BioNTech vaccine costs the EU 12 euros a dose (for about 300 million doses), the Modern slightly less than 15 euros (for 160 million doses). The least expensive is the vaccine produced by Oxford and AstraZeneca (only 1.78 euros per dose), on which the Italian government has focused the most when ordering 40 million doses and which, therefore, will be administered to a third of the Italians.
In total, the EU has ordered 400 million doses of AstraZeneca. However, the vaccine is unlikely to get approval from the EMA, the European drug agency, before February.
